{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:52:40Z","timestamp":1782625960609,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571605"],"award-info":[{"award-number":["81571605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701626"],"award-info":[{"award-number":["81701626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871303"],"award-info":[{"award-number":["81871303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clim.2021.108800","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T09:50:46Z","timestamp":1626601846000},"page":"108800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"229","author":[{"given":"Li","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108800_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2016.07.004","article-title":"Systemic-onset juvenile idiopathic arthritis","volume":"15","author":"Cimaz","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2021.108800_bb0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.clim.2021.108800_bb0015","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2021.108800_bb0020","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2021.108800_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2021.108800_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/14397595.2015.1060663","article-title":"Differential plasma microRNAs expression in juvenile idiopathic arthritis","volume":"26","author":"Ma","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clim.2021.108800_bb0035","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2021.108800_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cyto.2012.05.003","article-title":"Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages","volume":"60","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2021.108800_bb0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund\u2019s complete adjuvant: regulation by interferon-\u03b3","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2021.108800_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","article-title":"Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?","volume":"18","author":"Gohar","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2021.108800_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/imt-2017-0120","article-title":"PD-1\/PD-L1 in disease","volume":"10","author":"Kuol","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.clim.2021.108800_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0065","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2021.108800_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clim.2019.07.011","article-title":"Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis","volume":"207","author":"Yan","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13075-015-0859-z","article-title":"Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways","volume":"17","author":"Liu","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2021.108800_bb0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2326-6066.CIR-16-0329","article-title":"Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade","volume":"5","author":"Zhou","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.clim.2021.108800_bb0085","doi-asserted-by":"crossref","first-page":"e12884","DOI":"10.1111\/sji.12884","article-title":"Serum levels of soluble programmed death protein (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: association with activity and severity","volume":"92","author":"Du","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.40164","article-title":"Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis","volume":"69","author":"Fukasawa","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2021.108800_bb0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00592-017-1081-z","article-title":"Soluble programmed death-1 ligand 1(sPD-L1) is significantly reduced in the serum of type 1 diabetes patients","volume":"55","author":"Chen","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.clim.2021.108800_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1076029614562952","article-title":"Soluble programmed death 1 (PD-1) is decreased in patients with immune thrombocytopenia (ITP): potential involvement of PD-1 pathway in ITP immunopathogenesis","volume":"22","author":"Birtas","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.clim.2021.108800_bb0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jvh.13055","article-title":"Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B","volume":"26","author":"Zhou","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.clim.2021.108800_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jbspin.2018.03.003","article-title":"Decreased PD-1 expression on circulating CD4(+)T cell and PD-L1 expression on myeloid dendritic cell correlate with clinical manifestations in systemic juvenile idiopathic arthritis","volume":"86","author":"Cai","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2021.108800_bb0115","doi-asserted-by":"crossref","first-page":"108454","DOI":"10.1016\/j.clim.2020.108454","article-title":"Circulating dendritic cells are severely decreased in idiopathic pulmonary fibrosis with a potential value for prognosis prediction","volume":"215","author":"Galati","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091400","article-title":"Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2021.108800_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.canlet.2013.03.010","article-title":"Blockade of PD-1\/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice","volume":"336","author":"Ge","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.clim.2021.108800_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3899\/jrheum.161534","article-title":"Proposed core set of items for measuring disease activity in systemic juvenile idiopathic arthritis","volume":"45","author":"Limenis","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2021.108800_bb0135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2021.108800_bb0140","doi-asserted-by":"crossref","first-page":"108252","DOI":"10.1016\/j.clim.2019.108252","article-title":"Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"208","author":"Takakura","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12949","article-title":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1","volume":"188","author":"Bommarito","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3892\/mmr.2016.5968","article-title":"Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression","volume":"15","author":"Ren","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.clim.2021.108800_bb0155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/1346-8138.13339","article-title":"Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: association with extent of skin sclerosis","volume":"43","author":"Yanaba","year":"2016","journal-title":"J. Dermatol."},{"issue":"Suppl. 117","key":"10.1016\/j.clim.2021.108800_bb0160","first-page":"116","article-title":"Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study","volume":"37","author":"Yoon","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2021.108800_bb0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/sji.12509","article-title":"Serum sPD-L1, upregulated in sepsis, May reflect disease severity and clinical outcomes in septic patients","volume":"85","author":"Liu","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12967-016-1071-x","article-title":"Soluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS)","volume":"14","author":"Monaghan","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2021.108800_bb0175","article-title":"Soluble programmed death-1 (sPD-1) as predictor of early surgical outcomes of paediatric cystic echinococcosis","volume":"43","author":"Ben","year":"2021","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.clim.2021.108800_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","article-title":"Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis","volume":"26","author":"Avau","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2021.108800_bb0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108800_bb0190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1745-7254.2005.00086.x","article-title":"Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking Igv-like domain","volume":"26","author":"He","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.clim.2021.108800_bb0195","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3389\/fimmu.2018.01677","article-title":"Smoking is associated with low levels of soluble PD-L1 in rheumatoid arthritis","volume":"9","author":"Was\u00e9n","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:01Z","timestamp":1761494641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"alternative-id":["S1521661621001376"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108800","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108800"}}